PRMT1 and non-small cell lung carcinoma: The immunofluorescence results in our study showed that PRMT-1 was mainly localized in the nucleus and was upregulated in the resistant cell lines compared to parental cell lines and may induce EMT and potential drug resistance in the NSCLC cell lines H1975ER/OR and H3255ER/OR (Figure 4).